0001493152-23-043264.txt : 20231130 0001493152-23-043264.hdr.sgml : 20231130 20231130172732 ACCESSION NUMBER: 0001493152-23-043264 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231124 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231130 DATE AS OF CHANGE: 20231130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GlucoTrack, Inc. CENTRAL INDEX KEY: 0001506983 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980668934 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41141 FILM NUMBER: 231456708 BUSINESS ADDRESS: STREET 1: 301 RT 17 NORTH STREET 2: SUITE 800 CITY: RUTHERFORD STATE: NJ ZIP: 07070 BUSINESS PHONE: 972 (8) 675-7878 MAIL ADDRESS: STREET 1: 301 RT 17 NORTH STREET 2: SUITE 800 CITY: RUTHERFORD STATE: NJ ZIP: 07070 FORMER COMPANY: FORMER CONFORMED NAME: Integrity Applications, Inc. DATE OF NAME CHANGE: 20101203 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 24, 2023

GLUCOTRACK, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-41141

98-0668934

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

301 Rte 17 North, Ste. 800

Rutherford, NJ

07070

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (201) 842-7715

N/A

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		GCTK		Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR § 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously reported, on May 26, 2023, GlucoTrack, Inc. (the “Company”) received a letter from Nasdaq (the “Nasdaq letter”) that it no longer complies with Rule 5550(a)(2) of Nasdaq’s Listing Rules (the “Rules”) which require listed securities to maintain a minimum bid price of $1.00 per share. The Nasdaq letter stated that the Company had 180 calendar days, or until November 22, 2023, to regain compliance.

On November 24, 2023, the Company received a letter from Nasdaq notifying the Company that it has been granted an additional 180 calendar days, or until May 20, 2024 (the “Extended Compliance Period”), to regain compliance with the Minimum Bid Price Requirement in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If at any time during the Extended Compliance Period, the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days, the Staff will provide written confirmation that the Company has achieved compliance with the Minimum Bid Price Requirement. If the Company cannot demonstrate compliance during the Extended Compliance Period, the Staff will provide notice that the Company’s common stock will be subject to delisting. At that time, the Company may appeal the Staff’s determination to a hearings panel.

The Company intends to continue to monitor the closing bid price of its common stock and will consider available options to regain compliance with the Minimum Bid Price Requirement, including potentially implementing a reverse stock split (if approved by the Company’s shareholders). There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement during the Extended Compliance Period or will otherwise be in compliance with other Nasdaq listing requirements.

ltem 9.01 Exhibits

Exhibit		Description
99.1		Press Release dated November 30, 2023
104		Inline XBRL

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 30, 2023

	GLUCOTRACK, INC.

	By:	/s/ Paul Goode
	Name:	Paul Goode
	Title:	Chief Executive Officer

EX-99.1 2 ex99-1.htm

Exhibit 99.1

GLUCOTRACK ANNOUNCES 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement

Rutherford, NJ, November 30, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today it has received a notification letter from Nasdaq Stock Market LLC (“Nasdaq”) that the Company has been granted an additional 180-day compliance period, or until May 20, 2024, to regain compliance with Nasdaq’s minimum bid price rule.

In a notification letter dated May 26, 2023, Nasdaq informed the Company that, based on the previous 30 consecutive business days, the Company’s common stock no longer met the minimum $1.00 bid price per share requirement. Therefore, in accordance with Nasdaq’s Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until November 22, 2023, to regain compliance.

On November 24, 2023, the Company received a letter from Nasdaq notifying the Company that it is eligible for an additional 180 calendar day period to regain compliance (the “Extended Compliance Period”). Nasdaq’s determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the minimum bid price requirement, and the Company’s written notice of its intention to cure the deficiency during the Extended Compliance Period, and if necessary, by effecting a reverse stock split.

If, at any time before May 20, 2024, the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days, the Company will regain compliance with this Nasdaq rule.

This current notification from Nasdaq has no immediate effect on the listing or trading of the Company’s common stock, which will continue to trade on the Nasdaq Capital Market under the symbol “GCTK.”

About Glucotrack, Inc.

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes and prediabetes. The Company is currently developing a long-term implantable continuous glucose monitoring system for people living with diabetes. For more information, please visit http://www.glucotrack.com.

Investor Contact: investors@glucotrack.com

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “expect”, “plan” and “will” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect Glucotrack’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect Glucotrack’s results include, but are not limited to, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to the receipt (and timing) of regulatory approvals (including FDA approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to its current and future distribution agreements; risks relating to its ability to hire and retain qualified personnel, including sales and distribution personnel; and the additional risk factors described in Glucotrack’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including its Annual Report on Form 10-K for the year ended December 31, 2022 as filed with the SEC on March 31, 2023.

GRAPHIC 3 ex99-1_001.jpg begin 644 ex99-1_001.jpg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end EX-101.SCH 4 gctk-20231124.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 gctk-20231124_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 gctk-20231124_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Nov. 24, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Nov. 24, 2023
Entity File Number	001-41141
Entity Registrant Name	GLUCOTRACK, INC.
Entity Central Index Key	0001506983
Entity Tax Identification Number	98-0668934
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	301 Rte 17 North
Entity Address, Address Line Two	Ste. 800
Entity Address, City or Town	Rutherford
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07070
City Area Code	(201)
Local Phone Number	842-7715
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock
Trading Symbol	GCTK
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001506983 2023-11-24 2023-11-24 iso4217:USD shares iso4217:USD shares false 0001506983 8-K 2023-11-24 GLUCOTRACK, INC. DE 001-41141 98-0668934 301 Rte 17 North Ste. 800 Rutherford NJ 07070 (201) 842-7715 Common Stock GCTK NASDAQ false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://glucotrack.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm gctk-20231124.xsd gctk-20231124_lab.xml gctk-20231124_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "GCTK", "nsuri": "http://glucotrack.com/20231124", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "gctk-20231124.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "gctk-20231124_lab.xml" ] }, "presentationLink": { "local": [ "gctk-20231124_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://glucotrack.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-24", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-24", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://glucotrack.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-23-043264-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-043264-xbrl.zip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end